Stocktoria
Vir Biotechnology, Inc. VIR
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2019-10-11
Vir Biotechnology, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 16,434,122 | $146.3M | 11.78% |
| Point72 Asset Management, L.P. | 5,666,821 | $57.7M | 4.06% |
| TWO SIGMA INVESTMENTS, LP | 1,110,227 | $11.3M | 0.8% |
| CITADEL ADVISORS LLC | 1,044,637 | $10.6M | 0.75% |
| RENAISSANCE TECHNOLOGIES LLC | 1,016,864 | $10.4M | 0.73% |
| AQR CAPITAL MANAGEMENT LLC | 581,416 | $5.9M | 0.42% |
| D. E. Shaw & Co., Inc. | 416,403 | $4.2M | 0.3% |
| MILLENNIUM MANAGEMENT LLC | 47,993 | $489,049 | 0.03% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.